USPTO serial 79035384
PHYTONEERING
Reviewed by CopyMark Law Group
Reg. 3405721Status 709
- Filing date
- Status date
- Registration date
- Apr 1, 2008
- Examiner
- LE, KHANH M
- Law office
- —
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with PHYTONEERING?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
KENNETH F. FLORCK
Kenneth F. Florek FLOREK & ENDRES PLLC1156 Avenue of the AmericasSuite 600New York, NY 10036-2702Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | [ ESSENTIAL OILS FOR USE IN THE MANUFACTURE OF COSMETICS, HAIR LOTIONS, PERFUMERY, ORAL HYGIENE, DENTAL HYGIENE AND DENTIFRICES; PLANT EXTRACTS,TINCTURES AND FLAVORINGS IN LIQUID, SOLID OR GASEOUS FORM FOR COSMETICS, FOR HAIR LOTIONS AND PERFUMERY, NAMELY, HORSE CHESTNUT, MARSHMALLOW, ARNICA, BITTER ORANGE, BIRCH, MARIGOLD, CHAMOMILE, CONEFLOWER, HERB OF FIELD HORSE, GENTIAN, FIVE FINGERS, COUCH GRASS, HAMAMELIS, HIBISCUS, HOPS, HERB OF ST. JOHNS, JUNIPER, KRAMERIA, LICORICE, MALLOW, MELILOT, BALM, MILFOIL, PASSION, BURNET, PINE, PLANTAIN, OAK, ROSEMARY, WILLOW BARK, SAGE, THYME, RED CLOVER, NETTLE, HEARTS EASE, MISTLETOE ] | SECTION 71 - CANCELLED | — |
| 005 | [ PHARMACEUTICAL PREPARATIONS, NAMELY, PLANT EXTRACTS FOR USE IN THE TREATMENT OF ANGINA, ATHEROSCLEROSIS, BRONCHIAL ASTHMA, CIRCULATORY DISORDERS, CONSTIPATION, DIARRHEA, HEART FAILURE, HEART RHYTHM DISORDERS, HIGH BLOOD PRESSURE, INDIGESTION, INSOMNIA, MIGRAINE, MOTION SICKNESS, NAUSEA, PEPTIC ULCERS, VOMITING AND ALLERGY; PHARMACEUTICAL PREPARATIONS, NAMELY, PLANT EXTRACTS FOR USE AS AN ANTIDEPRESSANT, DIURETIC, HYPNOTIC, SEDATIVE, STIMULANT, AND TRANQUILIZER; PHARMACEUTICAL PREPARATIONS, NAMELY, FOR USE AS AN ANTIDEPRESSANT, DIURETIC, HYPNOTIC, SEDATIVE, STIMULANT, AND TRANQUILIZER; HEMORRHOIDAL OINTMENT, LAXATIVE, NASAL DECONGESTANT CAPSULES, NASAL SPRAY PREPARATIONS, NON-NARCOTIC ANALGESICS, THROAT LOZENGES; MEDICAMENTS FOR THE TREATMENT OF GYNECOLOGICAL DISORDERS AFFECTING MENSTRUATION, STERILITY, MENSTRUAL SYNDROMES, DYSMENORRHOEA, INFERTILITY, GENITAL TRACT INFECTIONS, PELVIC INFLAMMATORY DISEASES, VAGINAL DISCOMFORT DUE TO MENOPAUSAL ATROPHIC CHANGES, ANATOMICAL ABNORMALITIES, NEOPLASIA, BREAST NEOPLASM, BREAST CANCER, MAMMA, MASTOPATHY AND MASTODYNIA; MENSTRUATION CIRCULATION REGULATING TABLETS, HORMONE PREPARATIONS, MEDICINES FOR TREATING PREMENSTRUAL SYNDROME AND DYSMENORRHOEA; MEDICINES FOR THE TREATMENT OF BREAST PAIN; PHARMACEUTICAL PREPARATIONS FOR USE IN THE TREATMENT OF DISORDERS OF THE CIRCULATORY ORGANS, NAMELY, BLOOD CIRCULATION DISORDERS, HIGH BLOOD PRESSURE, HYPERTENSION, PULMONARY DISEASES, HEART RHYTHM DISORDERS AND HEART FAILURE; HORMONE REPLACEMENT MEDICATION; PHARMACEUTICAL AGENTS FOR THE TREATMENT OF DISORDERS OF THE URINARY, GENITAL AND ANAL ORGANS, NAMELY, FOR USE IN THE UROLOGY AND IN THE GENITOURINARY MEDICINE, FOR THE TREATMENT OF UROLOGICAL DISEASES, SEXUALLY TRANSMITTED DISEASES AND INFLAMMATORY PELVIC DISEASES; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF MENOPAUSAL COMPLAINTS DUE TO THERAPEUTICALLY INDUCED MENOPAUSE, TAMOXIFEN INDUCED HOT FLUSHES OF BREAST CANCER SURVIVORS, VAGINAL DISCOMFORT DUE TO MENOPAUSAL ATROPHIC CHANGES, CLIMACTIC SLEEP DISTURBANCES, DEPRESSIVE MOODS, OSTEOPROTECTION; PHARMACEUTICAL PREPARATIONS FOR THE PREVENTION OF OSTEOPOROSIS; DRUGS FOR CENTRAL NERVOUS SYSTEM, NAMELY, CENTRAL NERVOUS SYSTEM INFECTIONS, BRAIN DISEASES, CENTRAL NERVOUS SYSTEM MOVEMENT DISORDERS, OCULAR MOTILITY DISORDERS, SPINAL CORD DISEASES; ANTIDEPRESSANTS; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF PSYCHO VEGETATIVE DISORDERS, FOR DEPRESSIVE SYNDROME, FOR ANXIETY AND FOR NERVOUS UNREST; PHARMACEUTICAL PREPARATIONS FOR PERIPHERAL NERVOUS SYSTEM, NAMELY, PERIPHERAL NERVOUS SYSTEM INFECTIONS, PERIPHERAL NERVOUS SYSTEM MOVEMENT DISORDERS, NERVE COMPRESSION SYNDROMES, NEURITIS, NEURALGIA AND REGIONAL PAIN SYNDROMES; PHARMACEUTICAL PREPARATIONS FOR SENSORY ORGANS, NAMELY, FOR USE IN OPHTHALMOLOGY, OTOLARYNGOLOGY AND DERMATOLOGY; MEDICAMENTS FOR THE TREATMENT OF DISEASES AND DISORDERS OF THE KIDNEY; PHARMACEUTICAL PREPARATIONS AND PLANT EXTRACTS FOR THE TREATMENT OF THE KIDNEY AND UROLOGICAL DISORDERS, FOR CHRONIC INFECTIONS OF THE BLADDER, CYSTITIS, PYELONEPHRITIS, GLOMERULONEPHRITIS, INTERSTITIAL NEPHRITIS, NEPRHOLITHIASIS, SUPPORTIVE CANCER TREATMENT AND FOR UROLITH PROPHYLAXIS; PHARMACEUTICAL PREPARATIONS FOR TREATMENT OF BLOOD CONDITIONS AND DISORDERS; PILLS FOR TREATING DIZZINESS, MEDICAMENTS FOR REGULATION OF THE IMMUNE SYSTEM; PHARMACEUTICAL PREPARATIONS FOR TREATING MIGRAINE AND DEPRESSION; MEDICINES WITH SECRETOLYTIC, EXPECTORANTIC AND ANTIPHOGISTIC PROPERTIES FOR THE THERAPY OF INFLAMMATIONS OF THE UPPER AND LOWER RESPIRATORY ORGANS; PHARMACEUTICAL PREPARATIONS FOR TREATMENT OF SINUSES, BRONCHITIS AND RESPIRATORY TRACT; PHARMACEUTICAL PREPARATIONS, NAMELY, FOR THE TREATMENT OF TONSILLITIS, FOR STRENGTHENING THE IMMUNE SYSTEM, FOR THE TREATMENT OF RECIDIVATING DISEASES OF THE RESPIRATORY TRACT OR USED AS THERAPEUTIC PREPARATIONS FOR MOUTH AND THROAT; PHARMACEUTICAL PREPARATIONS MADE FROM WILLOW BARK, NAMELY, FOR USE IN THE TREATMENT OF MIGRAINE, ARTHRITIS, OSTEOARTHRITIS, FEVER, COUGH, COLD, DIARRHEA, PAIN, MENSTRUAL SYNDROMES AND PAIN, AND ALZHEIMER'S DISEASE; PHARMACEUTICAL PREPARATIONS FOR USE IN THE TREATMENT OF INFECTION OF RESPIRATORY TRACT, INFECTION OF URINARY TRACT, URINARY OBSTRUCTION, CHRONIC VENOUS INSUFFICIENCY, PROSTATE HYPERPLASIA, MUSCLE PAINS, SOFT TISSUE RHEUMATISM, MUSCULOSKELETAL DISEASE, LIVER DISEASE, HEPATITIS, CIRRHOSIS OF LIVER; PHARMACEUTICAL PREPARATIONS FOR USE IN THE TREATMENT, CURE, MITIGATION OR PREVENTION OF GINGIVITIS, HALITOSIS, STOMATITIS, PERIODONTITIS, INFLAMMATION OF THE ORAL CAVITY AND PHARYNGEAL CAVITY, HYPERSENSITIVITY OF TEETH; PHARMACEUTICAL PREPARATIONS FOR TREATING TEMPORARY RELIEF OF OCCASIONAL MINOR IRRITATION AND PAIN OF THE MOUTH, THROAT, LIPS, GUMS, TEETH, PAIN, SORE MOUTH, SORE GUMS, SORE THROAT, PAIN ASSOCIATED WITH CANKER SORES, PAIN DUE TO MINOR IRRITATION OR INJURY OF THE MOUTH AND GUMS, PAIN DUE TO MINOR DENTAL PROCEDURES, PAIN DUE TO MINOR IRRITATIONS CAUSED BY DENTURES OR ORTHODONTIC APPLIANCES, SORE GUMS DUE TO TEETHING IN INFANTS AND CHILDREN FOUR MONTHS OF AGE AND OLDER; PHARMACEUTICAL AND MEDICINAL PREPARATIONS AND SUBSTANCES, NAMELY, PREPARATIONS AND SUBSTANCES TO RELIEVE THE PAIN AND DISCOMFORT ASSOCIATED WITH SORE MOUTH, SORE GUMS, SORE THROAT, GINGIVITIS, STOMATITIS, PERIODONTITIS, HYPERSENSITIVITY OF TEETH AND OTHER DISEASES AND CONDITIONS OF THE MOUTH, GUMS, ORAL CAVITY AND PHARYNGEAL CAVITY; PHARMACEUTICAL PRODUCTS, NAMELY, MEDICATED DENTAL, GUMS AND MOUTH WASHES; MEDICATED DENTAL, GUMS AND MOUTH RINSE; PREPARATIONS FOR DENTAL PURPOSES, NAMELY, PLAQUE DISCLOSING REAGENTS, PERIODONTAL DIAGNOSTIC REAGENTS FOR MEDICAL PURPOSES FOR DETECTING DERIVATIVES FROM PERIODONTAL BACTERIA, CARIES DIAGNOSTIC REAGENTS FOR DETECTING DERIVATIVES FROM CARIES-CAUSAL BACTERIA AND MEDICINES FOR THE PREVENTION AND TREATMENT OF PERIODONTAL DISEASES, DENTAL CARIES, CANKER SORES, COLD SORES, MUCOSITIS AND ORAL AND TONGUE CANCERS; BIOLOGICAL PREPARATIONS FOR MEDICAL USE FOR THE TREATMENT AND PREVENTION OF PERIODONTAL DISEASES AND DENTAL CARIES; PHARMACEUTICAL PRODUCTS, NAMELY, MEDICATED TOOTHPASTES, MEDICATED ORAL-CARE GELS, MEDICATED DENTAL GELS, LOZENGES IN THE NATURE OF THROAT, MEDICATED LOZENGES, COUGH LOZENGES; MEDICATED CHEWING GUM; MEDICATED GELS AND FLUIDS IN THE NATURE OF DENTAL BLEACHING GELS, GUMS BALMS; PHARMACEUTICAL PRODUCTS, NAMELY, MEDICATED CHEWING GUMS AND LOZENGES WHICH PROVIDE A PROTECTIVE DENTAL OR GINGIVAL BARRIER, COATING OR SEALANT FOR PREVENTIVE, PROPHYLACTIC OR THERAPEUTIC HYGIENE USE; MEDICATED DENTAL FLOSS; MEDICATED DENTAL TAPES; MEDICATED DENTAL RIBBONS; MEDICATED TEETH WHITENER GELS; MEDICATED TOOTHPICKS, FLUORIDE CHEWING GUM AND CHEWABLE TABLETS FOR DISCLOSING DENTAL PLAQUE AND TARTAR; PHARMACEUTICAL PRODUCTS AND PREPARATIONS FOR ORAL, DENTAL AND GINGIVAL CARE; SANITARY PREPARATIONS FOR MEDICAL USE; SANITARY PREPARATIONS FOR HYGIENE, NAMELY, ANTISEPTICS, ORAL ANTISEPTICS, DISINFECTANTS FOR HEALTH PURPOSES; MEDICATED MOUTH SPRAYS AND DESENSITIZERS; ] DIETARY SUPPLEMENTS IN THE FORM OF TABLETS, DROPS, CAPSULES, EXTRACT PREPARATIONS, BALMS OR IN LIQUID FORM, CONTAINING PLANT EXTRACTS [ ; DIETETIC SUBSTANCES DERIVED FROM PLANTS, ADAPTED FOR MEDICAL USE IN THE FORM OF TABLETS, DROPS, CAPSULES, EXTRACT PREPARATIONS, BALMS OR IN LIQUID FORM, CONTAINING PLANT EXTRACTS; DIETETIC SUBSTANCES ADAPTED FOR MEDICAL USE IN THE FORM OF TABLETS, DROPS, CAPSULES, EXTRACT PREPARATIONS, BALMS OR IN LIQUID FORM; FOOD FOR MEDICALLY RESTRICTED DIETS, FOOD FOR DIABETICS, FOOD SUPPLEMENTS CONTAINING PLANT EXTRACTS, FOOD SUPPLEMENTS DERIVED FROM PLANTS OR PLANT EXTRACTS, ALL AFORESAID GOODS IN THE FORM OF TABLETS, DROPS, CAPSULES, EXTRACT PREPARATIONS, BALMS OR IN LIQUID FORM; DIETETIC SUBSTANCES DERIVED FROM PLANTS, ADAPTED FOR MEDICAL USE, NAMELY, FOOD FOR MEDICALLY RESTRICTED DIETS IN THE FORM OF TABLETS, DROPS, CAPSULES, EXTRACT PREPARATIONS, BALMS OR IN LIQUID FORM; FOOD SUPPLEMENTS AND DIETARY FOOD SUPPLEMENTS IN THE FORM OF TABLETS, DROPS, CAPSULES, EXTRACT PREPARATIONS, BALMS OR IN LIQUID FORM; VITAMIN AND. MINERAL SUPPLEMENTS; FOOD AND FOOD SUPPLEMENTS, NAMELY, HERBAL TEAS FOR MEDICINAL PURPOSES AND MEDICINAL TEAS; DISINFECTANTS FOR MEDICAL INSTRUMENTS; MEDICAL PLASTERS; WOUND, BURN AND SURGICAL DRESSINGS; MATERIAL FOR STOPPING TEETH; DENTAL WAX ] | SECTION 71 - CANCELLED | — |
| 016 | [ PRINTED MATTER, NAMELY, PUBLICATIONS IN THE FORM OF NEWSLETTERS AND BOOKLETS FOR USE BY PATIENTS REGARDING HEALTH AWARENESS, HEALTH INFORMATION, MEDICAL AND HEALTH CARE ISSUES AND DISEASE PREVENTION AND TREATMENT ] | SECTION 71 - CANCELLED | — |
| 030 | [ PLANT EXTRACTS, TINCTURES AND FLAVORINGS IN LIQUID, SOLID OR GASEOUS FORM FOR NON-NUTRITIONAL PURPOSES IN FOOD, NUTRITIONAL ADDITIVES, HERBAL TEAS ] | SECTION 71 - CANCELLED | — |
| 031 | [ PLANTS AND PARTS OF PLANTS, NAMELY, LIVING PLANTS, DRIED PLANTS, UNPROCESSED HERBS ] | SECTION 71 - CANCELLED | — |
| 035 | [ RETAIL PHARMACY SERVICES ] | SECTION 71 - CANCELLED | — |
| 044 | [ MEDICAL SERVICES OF A PHARMACY, NAMELY, PROVIDING INFORMATION REGARDING HEALTH AWARENESS, HEALTHY LIVING, AND DISEASE PREVENTION AND TREATMENT ] | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Bionorica AG
- Other trademarks owned by Bionorica AG
- Other trademarks owned by Bionorica SE
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 016
- Other trademarks in Class 030
- Other trademarks in Class 031
- Other trademarks in Class 035
- Other trademarks in Class 044
- Similar marks named PHYTONEERING
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 1, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 18, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 3, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 9, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 22, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 17, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 29, 2019 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Jul 28, 2019 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Jul 27, 2019 | INPC | INVALIDATION PROCESSED | — |
| Jul 2, 2019 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Nov 2, 2018 | C71T | CANCELLED SECTION 71 | — |
| Apr 1, 2017 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Feb 2, 2017 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Jan 26, 2017 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jun 20, 2015 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| May 4, 2015 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| May 4, 2015 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Dec 1, 2014 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jun 12, 2014 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 1, 2014 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Apr 1, 2014 | 71.P | REGISTERED - PARTIAL SEC 71 ACCEPTED | — |
| Mar 24, 2014 | 71AF | REGISTERED-SEC.71 FILED | — |
| Mar 24, 2014 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Dec 22, 2012 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 27, 2010 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 3, 2009 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Oct 16, 2008 | PLGL | ASSIGNED TO PARALEGAL | — |
| Sep 22, 2008 | AMD7 | SEC 7 REQUEST FILED | — |
| Sep 22, 2008 | PAPER RECEIVED | — | |
| Jul 17, 2008 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 17, 2008 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 3, 2008 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Jul 3, 2008 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 23, 2008 | PLGL | ASSIGNED TO PARALEGAL | — |
| Jun 23, 2008 | PLGL | ASSIGNED TO PARALEGAL | — |
| May 27, 2008 | AMD7 | SEC 7 REQUEST FILED | — |
| May 27, 2008 | PAPER RECEIVED | — | |
| Apr 1, 2008 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 15, 2008 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 26, 2007 | NPUB | NOTICE OF PUBLICATION | — |
| Dec 8, 2007 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Dec 7, 2007 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 5, 2007 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Oct 5, 2007 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 5, 2007 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 13, 2007 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Sep 13, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 13, 2007 | ALIE | ASSIGNED TO LIE | — |
| Aug 9, 2007 | PAPER RECEIVED | — | |
| May 4, 2007 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 17, 2007 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 17, 2007 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 14, 2007 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 13, 2007 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 12, 2007 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 2, 2007 | LIMS | LIMITATION OF GOODS/SERVICES FROM IB ENTERED | — |
| Mar 30, 2007 | NWAP | NEW APPLICATION ENTERED | — |
| Mar 29, 2007 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |